Clinical and Economic Impact of a Combination Haemophilus influenzae and Hepatitis B Vaccine | Zendy

A. Mark Fendrick | Zendy; Jason H. Lee | Zendy; Cory LaBarge | Zendy; Henry A. Glick | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical and Economic Impact of a Combination Haemophilus influenzae and Hepatitis B Vaccine

Author(s) -

A. Mark Fendrick,

Jason H. Lee,

Cory LaBarge,

Henry A. Glick

Publication year - 1999

Publication title -

archives of pediatrics and adolescent medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3628

pISSN - 1072-4710

DOI - 10.1001/archpedi.153.2.126

Subject(s) - medicine , hepatitis b virus , immunization , hepatitis b , vaccination , hepatitis b vaccine , pediatrics , cost effectiveness , cohort , vaccine efficacy , immunology , virus , hbsag , immune system , risk analysis (engineering)

Compliance with hepatitis B virus (HBV) vaccine remains suboptimal, despite a recommendation by the Advisory Committee on Immunization Practices of the US Public Health Service that all newborns be vaccinated. Although a combined HBV-Haemophilus influenzae type b (Hib) vaccine may improve acceptance of the HBV vaccine, the clinical and economic consequences of this intervention are uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research